Investing.com-- Bank of America (BofA) analysts highlighted several Japanese stocks as top picks following strong ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

Takeda (TAK) announced that the EMA has approved an additional two mL pre-filled pen option for Takhzyro for subcutaneous administration in ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

In our previous coverage of Alibaba Group Holding Limited, we've identified 3 impending catalysts to the stock: 1) core commerce reacceleration, 2) cloud arrival, and 3) a potential Apple ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Founder and CEO of Zander's Game House, Jeanne Slkoff, spoke about her business during Spring Semester Entrepreneur Speaker ...